SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $830,000 | +10275.0% | 404,600 | +67558.9% | 0.00% | – |
| Q1 2021 | $8,000 | -84.3% | 598 | -81.2% | 0.00% | – |
| Q4 2020 | $51,000 | +537.5% | 3,184 | +364.8% | 0.00% | – |
| Q3 2020 | $8,000 | -50.0% | 685 | -40.2% | 0.00% | – |
| Q2 2020 | $16,000 | +23.1% | 1,145 | -15.6% | 0.00% | – |
| Q4 2019 | $13,000 | +30.0% | 1,357 | +41.9% | 0.00% | – |
| Q3 2019 | $10,000 | 0.0% | 956 | +7.9% | 0.00% | – |
| Q2 2019 | $10,000 | – | 886 | +3307.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 26 | -80.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 130 | +120.3% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 59 | +25.5% | 0.00% | – |
| Q2 2018 | $1,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $17,639,000 | 16.57% |
| Aquilo Capital Management, LLC | 1,054,356 | $13,506,000 | 5.98% |
| VHCP Management II, LLC | 474,015 | $6,072,000 | 1.78% |
| AWM Investment Company, Inc. | 562,296 | $7,203,000 | 1.42% |
| Alphabet Inc. | 1,112,473 | $14,251,000 | 0.74% |
| BVF INC/IL | 460,706 | $5,902,000 | 0.66% |
| DAFNA Capital Management LLC | 70,000 | $897,000 | 0.39% |
| Artal Group S.A. | 600,000 | $7,686,000 | 0.31% |
| Rock Springs Capital Management LP | 525,000 | $6,725,000 | 0.26% |
| Orbimed Advisors | 507,471 | $6,501,000 | 0.10% |